NIH All of Us Study Finds Thousands of New Drug-Response Gene Variants
A study of nearly 100,000 participants in the National Institutes of Health's All of Us program, published Wednesday in Science Translational Medicine, found thousands of previously unreported variants in 16 genes that affect how people respond to drugs such as statins, SSRIs, chemotherapy and the blood thinner Plavix, STAT reports. Every participant carried at least one variant, and one in four had taken a medicine the variants could affect. The program expects about $122 million in funding this year, which STAT says is 80 percent below its 2023 peak.
Sources